Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Boehringer slots synthetic lethal program into oncology pipeline
Boehringer has partnered with Tessellate Bio on a synthetic lethal program in a deal worth more than 500 million euros in biobucks.
Nick Paul Taylor
Apr 23, 2025 7:45am
Sponsored
Fortrea’s Gani Chico Talks Oncology Innovation, AI and Clinical Trial Strategy
Apr 21, 2025 8:00am
Ascletis sees no benefit to high, fast oral GLP-1 dose titration
Apr 23, 2025 7:25am
Genentech builds autoimmune Repertoire with $765M deal
Apr 23, 2025 7:00am
Sanofi hands cancer drug to Innate as it pivots R&D pact focus
Apr 23, 2025 6:35am
Ypsomed sells diabetes business to focus on GLP-1 self-injectors
Apr 23, 2025 6:20am
More News
German cancer antibody biotech eyes SPAC as route to Nasdaq
Apr 23, 2025 6:09am
BD launches surgical monitor with AI blood pressure predictions
Apr 22, 2025 2:00pm
Biolinq raises $100M to carry glucose sensor patch to the FDA
Apr 22, 2025 12:00pm
Harvard sues Trump admin over threats to freeze research funds
Apr 22, 2025 10:54am